Avenue Therapeutics Inc. buy quelbe60
Start price
18.01.23
/
50%
€2.16
Target price
18.01.24
-
Performance (%)
-34.95%
End price
21.01.23
€1.41
Summary
This prediction ended on 21.01.23 with a price of €1.41. Massive losses of -34.95% were the result for the BUY prediction by quelbe60. quelbe60 has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Avenue Therapeutics Inc. | - | - | -87.239% |
iShares Core DAX® | 0.000% | -2.064% | 13.111% |
iShares Nasdaq 100 | 0.626% | -2.884% | 37.744% |
iShares Nikkei 225® | 1.568% | -5.892% | 19.592% |
iShares S&P 500 | 0.334% | -2.281% | 27.745% |
According to quelbe60 what are the pros and cons of Avenue Therapeutics Inc. for the foreseeable future?
Pros
Cons
Risky Investment
Comments by quelbe60 for this prediction
In the thread Avenue Therapeutics diskutieren
Buy Avenue Therapeutics Inc.
In the thread Trading Avenue Therapeutics
Buy beendet
Stopped prediction by quelbe60 for Avenue Therapeutics Inc.
Avenue Therapeutics Inc.
Start price
Target price
Perf. (%)
€14.42
03.10.22
03.10.22
-
03.10.23
03.10.23
-81.66%
07.10.22
07.10.22
Risky Investment
Avenue Therapeutics Inc.
Start price
Target price
Perf. (%)
€10.76
30.09.22
30.09.22
-
30.09.23
30.09.23
39.41%
03.10.22
03.10.22
Risky Investment